JOHN FISHER MD, CEO
Praxis Medical was founded by Dr. John Fisher MD in 2018. Dr. Fisher has spent the last 30 years leveraging his vast medical knowledge to innovate products that address unmet clinical needs for doctors, patients, and providers. He has served as the Chief of Interventional Radiology at Morton Plant Hospital for over 13 years and the CEO of Biopsy Sciences since 2000. At Biopsy Sciences he and his partners developed the HydroMark breast biopsy marker (acquired by Devicor in 2014), the Bio-SEAL biopsy tract sealant (now BioSentry acquired by Angiodynamics in 2018), and the Maxi-Cell needle (acquired by Angiotech in 2004).
At Praxis Medical, Dr. Fisher has developed CytoCore to revolutionize the soft tissue biopsy space.
Praxis Medical provides consulting services in the field of providing quality assurance services in the field of biotechnology, pharmaceuticals, medical devices, and healthcare; research and development and consultation thereto in the fields of biotechnology, pharmaceuticals, medical devices and healthcare. We also off regulatory compliance consulting in the fields of biotechnology, pharmaceuticals, medical devices and healthcare